Prevention of delirium tremens: use of phenothiazines versus drugs cross-dependent with alcohol.
D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001679:Biogenic Amines / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D004361:Drug Tolerance; D004569:Electroencephalography; D000431:Ethanol; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D010424:Pentobarbital / Q000627:therapeutic use; D010919:Placebos; D011604:Psychoses, Alcoholic / Q000517:prevention & control*; D012640:Seizures / Q000188:drug therapy; D012894:Sleep Stages; D012895:Sleep, REM; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D013831:Thiamine / Q000627:therapeutic use
D014150:Antipsychotic Agents; D001679:Biogenic Amines; D006993:Hypnotics and Sedatives; D010919:Placebos; D006919:Hydroxyzine; D000431:Ethanol; D002707:Chlordiazepoxide; D010424:Pentobarbital; D002746:Chlorpromazine; D013831:Thiamine